97873713 - BIOMARK

Information

• Trademark
• 97873713

• Source

• Serial Number

  97873713

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  April 05, 2023
  a year ago

• Transaction Date

  June 11, 2024
  6 months ago

• Status Date

  June 11, 2024
  6 months ago

• Location Date

  June 11, 2024
  6 months ago

• Status Code

  653

• Current Location

  TMO LAW OFFICE 115

  Employee Name

  CHUNG, ABBIE

• Attorney Docket Number

  58716/5812

  Law Office Assigned Location Code

  M60

• Owners

  • BIOMARK CANCER SYSTEMS INC

Case File Statements

• GS0051: Antibody reagents for in vitro diagnostic use for medical purposes; diagnostic kits consisting of monoclonal antibodies, buffers, and reagents for in vitro diagnostic use for medical purposes; medical diagnostic antibody reagents for use in medical imaging; diagnostic kits consisting of monoclonal antibodies, buffers and reagents for specialized medical Raman spectrometry to monitor toxicity of drugs for medical purposes, for use in disease testing, for testing of bodily fluids for use in disease detection, namely, cancer, for screening the acetylated form of Amantadine in body fluids and human tissues samples, for use in the early detection of cancer by detecting and analyzing the levels of Spermine/Spermidine N-Acetyl Transferase (SSAT) in human tissue samples; medical diagnostic assays for testing bodily fluids in drug screening applications, namely, assays for determining the efficacy of anti-cancer drugs; medical diagnostic assays for testing bodily fluids that test for the presence and effects of drug candidates in the body; drug testing kits comprised of medial diagnostic reagents and assays for testing body fluids; medical diagnostic reagents and assays for the analysis of body fluids; diagnostic biomarker reagents for medical purposes
• GS0441: Medical testing of a biological sample taken from a patient for diagnostic purposes in the field of oncology; medical testing of a biological sample taken from a patient for medical screening purposes in the field of oncology; providing medical evaluation to assess and measure response to cancer treatment; medical analysis services relating to the treatment of cancer patients to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; medical diagnostic testing, monitoring and reporting services relating to disease recurrence and progression in the field of oncology; providing medical support in the monitoring of patients receiving medical treatments, namely remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes, interactive medical monitoring and alert service for reminding clients of medical dosage, allergic sensitivity and prescription refills for medical treatment purposes; providing medical information to medial professionals in the form of analytical reports and risk classification or stratification in the field of oncology; providing medical information to patients and medical professionals in the form of reports in the field of oncology
• GS0421: Providing an interactive web site featuring technology that enables users to enter, access, track, store, monitor, analyze and generate health and medical information and reports

Case File Event Statements

• 4/8/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 5/1/2023 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 1/2/2024 - a year ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/12/2024 - 11 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/12/2024 - 11 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/12/2024 - 11 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/12/2024 - 8 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/12/2024 - 8 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/12/2024 - 8 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/11/2024 - 6 months ago

  12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3

• 6/11/2024 - 6 months ago

  10 - SUSPENSION LETTER WRITTEN Type: CNSL

• 6/11/2024 - 6 months ago

  11 - LETTER OF SUSPENSION E-MAILED Type: GNSL